STROKE MODELS
Holistic approaches to your in vivo stroke studies.
According to the American Heart Association (AHA), stroke is the 5th leading cause of death in the USA, and every 4 out of 5 strokes are ischemic in nature: they are caused by a thrombus or embolus clogging one of the major cerebral arteries, or their branches.
The complex pathophysiologic nature of ischemic strokes makes it challenging to only use a single animal model that encompases all the different facets of the disease. At PharmaLegacy, our Intracerebral Hemorrhage model and our Ischemia-reperfusion Stroke Induced by MCAO model provide your preclinical studies with a more holistic approach on the disease. Need to know more? Contact us and let one of your experts give you all the answers you need.
MODELS / SERVICES
Seamless pipelines:
- Scientific staff with an average of over 15 years of experience in pharmacology
- Operations and IT structured for maximum protection of clients’ data and IP
- Capacity to run 200+ concurrent animal studies.
- AAALAC accredited vivarium
Choose quality above all. Choose PharmaLegacy.
We’re ready when you are.
Tell us your pharmacology challenges.
